EP1616567A1 — Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts
Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2006-01-18 · 20y expired
What this patent protects
The present invention relates to novel pharmaceutical compositions based on PDE IV inhibitors 2 and salts of formula 1 wherein X - may have the meanings defined in the description and claims, processes for preparing them and their use in the treatment of respir…
USPTO Abstract
The present invention relates to novel pharmaceutical compositions based on PDE IV inhibitors 2 and salts of formula 1 wherein X - may have the meanings defined in the description and claims, processes for preparing them and their use in the treatment of respiratory complaints.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.